Abstract To improve the secretion and expression of human interferon alpha 2b (IFN) in Lactococcus lactis, a synthetic pro-peptide, LEISSTCDA (LEISS), was fused to the N-terminus of IFN. This gave a higher secretion efficiency (12% vs. 5%) and yield (*2.8-fold) of IFN. The signal peptide, SP SlpA (SlpA, an S-layer protein of Lactobacillus brevis), was also tested to secrete IFN instead of SP Usp45 (Usp45, the main secreted protein in L. lactis). This gave increased IFN secretion (*3-fold) but lower total production. All the recombinant IFN had appropriate bioactivities in an antiviral assay.
Introduction
Human interferon alpha 2b (huIFN-a2b) is a type I interferon which is a growing family of cytokines with antiviral, anti-proliferative, and immunomodulatory activities. Currently, huIFN-a2b (hereafter called IFN) is used worldwide for the treatment of serious diseases such as hepatitis B and C (ChelbiAlix and Wietzerbin 2007) .
Several host-vector systems have been used to express IFN, including Escherichia coli (Srivastava et al. 2005) , Pichia pastoris (Shi et al. 2007 ) and transgenic potato plants (Ohya et al. 2001) . To offer an additional food-grade expression system, Lactococcus lactis, a 'generally regarded as safe' (GRAS) microorganism, was chosen as the host to produce IFN in our previous study. The protein IFN was directed by signal peptide SP Usp45 (Usp45, the main secreted protein in L. lactis) but the secretion level was low as revealed by Western blot analysis (Zhang et al. 2010) . SP Usp45 has been used to secret a wide variety of heterologous proteins from bacterial and viral origins at high levels (Le Loir et al. 2005) . A signal peptide SP SlpA (SlpA, originating from an S-layer protein of Lactobacillus brevis), gave a more efficient secretion of the E. coli FedF adhesin than SP Usp45 (Lindholm et al. 2004) . In some cases, the fusion of a nine-residue pro-peptide LEISSTCDA (hereafter called LEISS) enhanced the secretion of foreign proteins in L. lactis (Le Loir et al. 1998 ). Here, we evaluated whether the fusion of LEISS or the use of SP SlpA could improve the IFN secretion by L. lactis. Both the secretion and yield of IFN were efficiently improved by the fusion of LEISS while the use of SP SlpA only enhanced the secretion efficiency but not the production of IFN. All the recombinant IFN produced were bioactive as demonstrated by an antiviral assay.
Materials and methods

Bacterial strains, plasmids and culture conditions
The bacterial strains and plasmids used are given in Supplementary Table 1. E. coli was grown in LuriaBertani (LB) medium at 37°C. L. lactis was grown in M17 medium supplemented with 0.5% (w/v) glucose (GM17) at 30°C without shaking. For plasmid selection, the antibiotics were: ampicillin, 100 lg ml -1 for E. coli; chloramphenicol, 10 and 5 lg ml -1 for E. coli and L. lactis, respectively. Nisin was added at 10 ng ml -1 to induce protein expression in L. lactis.
Plasmid construction
In addition to pNZ-ifnm (Zhang et al. 2010) , three expression plasmids were constructed to produce and secrete IFN in L. lactis, whose schematic diagrams are shown in Fig. 1 . Nucleotide sequence, TTGGAAATATCGTCGA CTTGTGATGCT encoding the propeptide LEISS, was fused to the 5 0 -end of the ifnm gene. The fusion fragment leiss-ifnm was digested by SacI and KpnI and cloned into the same digested pUC45-ifnm, resulting in plasmid pUC45-LEISS-ifnm. Then the SP Usp45 -leiss-ifnm fragment was amplified, digested by NcoI and KpnI enzymes and ligated into NcoI/ KpnI-cut pNZ8048 backbones, resulting in plasmid pNZ-LEISS-ifnm.
To test if SP SlpA could increase IFN secretion efficiency, the gene SP SlpA was amplified from the genomic DNA of Lb. brevis and digested by EcoRI and SacI enzymes. The purified SP SlpA fragment was cloned into the same cut plasmids pUC45-ifnm and pUC45-LEISS-ifnm to generate pUC46-ifnm and pUC46-LEISS-ifnm, respectively. Then the fragments SP SlpA -ifnm and SP SlpA -leiss-ifnm were amplified, digested by NcoI and KpnI and inserted into the NcoI/KpnI-cut pNZ8048, getting the plasmids pSPifnm and pSP-LEISS-ifnm.
All the three vectors (pNZ-LEISS-ifnm, pSP-ifnm, and pSP-LEISS-ifnm) were transformed into L. lactis NZ9000 using a Gene Pulser Apparatus (Bio-Rad, USA) at 2,000 V, 25 lF and 200 X. The empty vector pNZ8048 was also transformed into L. lactis NZ9000 as a negative control.
Protein extraction and immunoblotting in L. lactis
The recombinant L. lactis strains were grown to an OD 600 of 0.5-0.6 and induced with 10 ng nisin ml -1 (Sigma) for 6 h. The cellular and supernatant fractions were prepared as described previously (Zhang et al. 2010) . SDS-PAGE and immunoblotting analysis with a mouse monoclonal antibody to IFN (Abcam, ab9386) were performed as described (Zhang et al. 2010 ).
Measurement of concentration and biological activity of IFN
The concentrations of IFN secreted into the culture medium and retained in the cell fractions of the recombinant strains were analyzed with a two-site enzyme-linked immunosorbent assay (ELISA) kit according to manufacturer's recommendations.
A standard cytopathic effect inhibition assay using Vesicular Stomatitis Virus (VSV) challenge of human amniotic WISH cells (kindly provided by Ms. Ling Fu at Institute of Microbiology and Epidemiology, Beijing, China) was performed to quantify the antiviral activity of the IFN in the sample preparation (Rubinstein et al. 1981) . The IFN activity is expressed as international units (IU) relative to the Human leukocyte IFN standard with a predicted titer of 1.1 9 10 4 IU, which was purchased from the National Institute for the Control of Pharmaceutical and Biological Products, China.
Results and discussion
Construction of recombinant L. lactis strains for enhancement of IFN secretion Recombinant IFN was secreted by signal peptide SP Usp45 under the control of P nisA promoter in plasmid pNZ-ifnm in our previous study. But the secretion efficiency of IFN was low as shown by Western blot analysis (Zhang et al. 2010) . To enhance the IFN secretion by L. lactis, the pro-peptide LEISS was fused to the N-terminus of IFN and the resulting plasmid pNZ-LEISS-ifnm was obtained (Fig. 1a) . Signal peptide SP SlpA was also used to try to increase the secretion efficiency of IFN. As a result, two more plasmids pSPifnm ( Fig. 1B ) and pSP-LEISS-ifnm ( Fig. 1c) were constructed in this study. All the three expression plasmids (pNZ-LEISS-ifnm, pSP-ifnm, and pSP-LEI-SS-ifnm) were transformed into food-grade bacterium L. lactis NZ9000. The resulting strains NZI-LEISS, NZP, and NZP-LEISS were investigated for the expression of recombinant proteins.
LEISS significantly improves secretion efficiency and yield of IFN in L. lactis IFN production in the NZI-LEISS strain was firstly evaluated and compared with the NZI strain through SDS-PAGE (Fig. 2) analysis. L. lactis NZ9000 containing plasmid pNZ8048 (NZV) was used as a negative control. Induced protein bands were clearly visible in the cellular fractions from the NZI and NZI-LEISS strains with the expected sizes of 22 and 23 kDa. These correspond to the precursor forms of IFN and LEISS-IFN, respectively (Fig. 2) . No specific band could be detected in the supernatant samples from both strains which was probably due to the low secretion yield (data not shown).
Recombinant IFN was further confirmed by immunostaining using a mouse monoclonal antibody Protein extracts from induced cultures of IFN-producing L. lactis NZ9000 strains were prepared and analyzed by SDS-PAGE as described in the ''Methods'' section. L. lactis transformed with pNZ8048 (NZV) was used as a negative control. Cells from 5 ml cultures were harvested and concentrated to 500 ll. After sonication, 15 ll of the samples were loaded. Stars indicate the positions of the IFN and LEISS-IFN proteins. Molecular mass markers are indicated on the left side against IFN (Fig. 3) . As previously observed, clear bands were detected at *22 and 19 kDa in the cellular and supernatant samples from the NZI strain, respectively. Two bands (23 and 20 kDa) were shown to indicate the precursor and mature forms of LEISS-IFN in the cellular and supernatant fractions from the NZI-LEISS strain, respectively (Fig. 3) . Western blotting revealed that more intense extracellular signal was observed from the NZI-LEISS strain than that from the NZI strain, suggesting more effective processing and secretion of LEISS-IFN.
The yields of IFN produced by the two strains were determined (Table 1 ). The secretion efficiency of LEISS-IFN was improved from 5 to 12% and total protein production was enhanced *1.5-fold compared to IFN without LEISS. The negatively charged pro-peptide LEISS can improve the secretion of heterologous proteins by altering the N-terminus charge of the mature proteins (Le Loir et al. 1998) . Interestingly, our results as well as studies found that not only the secretion efficiency but also the total quantity of the proteins could be improved by the fusion of LEISS (Le Loir et al. 1998; Nouaille et al. 2005 ).
SP Usp45 is superior over SP SlpA in this study
To test if the signal peptide SP SlpA could secret IFN more efficiently than SP Usp45 in L. lactis, expression vector pSP-ifnm was constructed in which SP SlpA was used. Once the plasmid was established into L. lactis NZ9000, protein secretion in the NZP strain was evaluated by SDS-PAGE (Fig. 2) and Western blotting (Fig. 3) . In SDS-PAGE, no specific band was observed either in the cellular (Fig. 2) or in the supernatant sample (data not shown) from the NZP strain. While the intracellular SlpA-IFN expression could be detected by Western blotting at the expected size of 45 kDa. In the medium from the NZP strain, however, a band (*13 kDa) of smaller than expected size was found (Fig. 3) .
We also analyzed the effect of the fusion of LEISS between SP SlpA and the mature moiety of IFN. As a result, recombinant L. lactis NZ9000 strain containing plasmid pSP-LEISS-ifnm (NZP-LEISS) was constructed. Although no specific band was found in the cellular fraction from the NZP-LEISS strain in SDS-PAGE (Fig. 2) , a single band was detected by Western blotting corresponding to the precursor form of SlpA-LEISS-IFN (46 kDa). In the supernatant fraction from this strain, the *13 kDa band was also found (Fig. 3) .
Although a *13 kDa protein appeared in the medium from both the NZP and NZP-LEISS strains, it was smaller than expected but was recognized by the anti-IFN antibodies in Western blotting and ELISA. Subsequent antiviral assay revealed that the Production of IFN was further examined in recombinant L. lactis strains by Western blotting using an anti-IFN antibody. Different quantities of the samples extracted from cellular (C) and supernatant (S) fractions of the four recombinant strains were loaded on SDS-PAGE. For the cellular fractions of the four recombinant strains, cells from 5 ml cultures were harvested and concentrated to 500 ll. After sonication, 3 ll (for NZI and NZI-LEISS) or 9 ll (for NZP and NZP-LEISS) of the cellular samples were loaded onto the gels. For the supernatant fractions of the four recombinant strains, 5 ml supernatant samples was precipitated with TCA and dissolved with 500 ll NaOH. The samples (15 ll) were then analyzed by western blotting. Molecular mass markers are indicated on the right side. NZI: L. lactis NZ9000/pNZ-ifnm; NZI-LEISS: L. lactis NZ9000/pNZ-LEISS-ifnm; NZP: L. lactis NZ9000/pSP-ifnm; NZP-LEISS: L. lactis NZ9000/pSP-LEISSifnm; and NZV: L. lactis NZ9000/pNZ8048 protein was still bioactive. We thus concluded that it must be a part of IFN. The *13 kDa protein was then regarded as the secreted protein produced by the NZP and NZP-LEISS strains and its production in the two strains was calculated by ELISA. Table 1 shows that the secretion efficiencies of IFN in the NZP and NZP-LEISS strains are 60 and 26%, respectively. The total IFN productions are about 0.5 lg l -1 in both strains. The fusion of LEISS leads to lower secretion efficiency and does not exert significant increase of IFN yield in NZP-LEISS.
The reason why the *13 kDa protein was smaller than expected remained unknown. The signal peptide SP SlpA used in this study was originated from an S-layer protein of Lb. brevis ATCC8287, which is not frequently used in L. lactis. While in one study when SP SlpA was employed to secret Ply511 (lytic enzyme of Listeria monocytogenes) in L. lactis MG1363, a band smaller than expected was found secreted into the medium. Subsequent analysis revealed a deletion that occurred within the 3 0 -end coding sequence of SlPA-Ply511 (Gaeng et al. 2000) . The deletion may not happen in the SlpA-IFN and SlpA-LEISS-IFN fusion proteins as their intracellular forms met the corresponding size. The secreted proteins with smaller size may be due to the incorrect processing or degradation and will be studied in our future work. SP Usp45 is the most widely used signal peptide in L. lactis that secrets many heterologous proteins efficiently (Le Loir et al. 2005) . However, SP slpA also can drive the secretion of the E. coli FedF adhesin more efficiently than SP Usp45 (Lindholm et al. 2004 ). In present work, we compared the secretion efficiency of IFN directed by SP SlpA and SP Usp45 . SP SlpA gave a higher secretion in the NZP (60%) and NZP-LEISS (26%) strains than SP Usp45 (5% in the NZI strain and 12% in the NZI-LEISS strain). However, the total IFN production in the two strains using SP SlpA (0.5 lg l -1 ) was much lower than those using SP Usp45 (1.6 lg l -1 in the NZI strain and 2.4 lg l -1
in the NZI-LEISS strain) (Table 1) . Moreover, the proteins secreted into the medium were smaller than expected. Thus, the results indicate that SP Usp45 is still superior over SP SlpA in this study.
Biological activity of IFN produced by L. lactis
The biological activity of IFN from all the four nisininduced recombinant L. lactis strains was studied by the VSV cytopathic effect reduction assay using the WISH cells line. The intracellular and secreted IFN in the NZI strain displayed the same level of antiviral activity at 2 9 10 6 IU mg -1 . The fusion of LEISS led to a slightly increase of IFN activity either in the cellular (3.5 9 10 6 IU mg -1 ) or in the supernatant fraction (3 9 10 6 IU mg -1 ) from the NZI-LEISS strain compared with that from the NZI strain (Fig. 4) . Fusion of peptide or protein to the IFN may increase or decrease its bioactivity. For example, fusion with ATS (C-terminal tail of a-synuclein, 119-140 residues) to the C-terminus of IFN-a1 appeared to be 1.6 times more bioactivity than the native IFN-a1 presumably due to the increased stability of the fusion protein (Kim et al. 2009 ). The increased activity of LEISS-IFN in the NZI-LEISS strain might also attribute to the more stability of the fusion protein compared to IFN.
In the cellular fractions from the NZP and NZP-LEISS strains, the IFN biological activities were comparable to those from the NZI strain, i.e. 2 9 10 6 IU mg -1 . The part of IFN protein in the medium from the two strains still displayed bioactivities at 0.2 9 10 6 IU mg -1 (Fig. 4) . As the multiple biofunctions of IFN are mediated by the interaction between IFN and its receptors (Chelbi-Alix and Wietzerbin 2007), the truncated IFN may retain partial IFNreceptor recognition sites. Two domains, defined by residues 29-35 and 123-140, are responsible for IFNreceptor binding interaction and constitute receptor recognition sites in IFN (Fish 1992) . Some truncated IFNs, without damage of these domains, still retained bioactivity, e.g. a truncated IFN without the five C-terminal residues had the same antiviral activity as the native IFN (Piehler et al. 2000) . Antiviral activity, the principal biological activity induced by IFN, was originally used to define IFN. This feature makes IFN effective in the treatment of some chronic and infectious diseases. Recombinant IFN with high biological activity has been obtained at *10 8 -10 9 IU mg -1 in E. coli (Srivastava et al. 2005) and Pichia pastoris (Shi et al. 2007 ) but complicated purification procedures and high-dose injection are needed when IFN is used clinically. An orally-delivered transgenic potato system was also employed to express IFN, but the activity of this recombinant IFN was very low (only 567 IU g -1 tissue) (Ohya et al. 2001) . In the present study, we demonstrated that food-grade L. lactis strains were able to produce and secret IFN, and the highest antiviral activity recovered was 3.5 9 10 6 IU mg -1 . Interestingly, studies on oral administration of low doses of IFN-a suggest that doses as low as 10 IU per mouse reduce the viral burden of murine cytomegalovirus (Bosio et al. 1999) , and 150 IU per person three times daily improves Sjogren's syndrome salivary gland dysfunction (Ship et al. 1999) . Thus, recombinant IFN-producing L. lactis strains with GRAS status could deliver IFN at the mucosal level and would be less costly, safer, and more convenient compared to current IFN drug therapy.
Conclusion
In summary, our results showed that the fusion of LEISS improved both IFN secretion and production by L. lactis, and signal peptide SP Usp45 was better than SP SlpA in this study. Besides, recombinant IFN produced by all the four strains were biologically active as demonstrated by an antiviral assay. These recombinant strains provide more attractive vectors to deliver active IFN at the mucosal level, which represents a new therapeutic delivery strategy for this classic cytokine in the medical field.
